Elvira Zini
Scientific & Technical Affairs Director
Laboratorios Richmond SACIF
Buenos Aires, Argentina
In charge of biotech & small chemical entities R&D, Regulatory Activities, Licensees and Tech Transfer agreements.
Sobre
Elvira Zini, M.Sc. is the Scientific & Technical Affairs Director of Laboratorios Richmond SACIF Argentina, a LATAM Pharmaceutical and Biotech company where she has been working since 1996 and in charge of different positions. She has vast experience in the pharmaceutical industry, she also worked 10 years for Boehringer Ingelheim, R&D Division and for John Wyeth.
She has a Master Degree in Chemical Sciences, Biological Chemistry Orientation, College of Exact and Natural Sciences-UBA Argentina, and received many post graduate education.; i.e. Pharmaceutical Technology Training at Pharmacy College Ghent University Belgium, that acceded through a Scholarship of the Foreign Trade and Development Cooperation Ministry, Kingdom of Belgium. She also has business education, i.e. PDD IAE Business School, Universidad Austral, Argentina
She is one of the founders of a NGO, “De La Nada Asociación Civil”, where she is a volunteer for more than 23 years.
Mi organización
Regional pharmaceutical company based in Argentina devoted to the development and manufacture of technologically advanced pharmaceutical products.
Richmond believes that health-care is not a privilege. This right implies providing equality of access to the best treatments, also to therapies which would make access difficult due to their high costs.
the product portfolio includes biosimilar products, vaccines, generic products licenses and technology transfers from central countries. In addition, we have developed innovative solutions which combine different active ingredients in a single tablet presented in user friendly packaging for ease of transportation and intake. This allows patients to adhere to the treatment while enjoying an active life.
During 2024 a new state-of-art vaccines & biotechnology facility is being opened, facility that includes premium technology for drug substance and drug product manufacturing. Supportive comprehensive quality control labs and pilot plant for process development and technology transfer.
Habilidades
- R&D
- Drug Regulatory Affairs
Intereses
- Business oportunites
- CDMO service provider
- vaccines
- Biosimilars
Preguntas adicionales
¿Cuáles son sus áreas de negocio?
What are your intends at this event?
Sesiones de ponente (1)
lunes, 8 de abril de 2024
16:50 - 17:35
Convergencia regulatoria y barreras de entrada
Retos para la armonización regulatoria